Cargando…
Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study
Pregnant women and newborns are considered a subgroup of population at increased risk for several infectious diseases, some of which are vaccine-preventable. Anti-diphtheria-tetanus-pertussis vaccine (dTpa) and influenza vaccine are recommended for pregnant women. We carried out a study to evaluate...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067467/ https://www.ncbi.nlm.nih.gov/pubmed/35180368 http://dx.doi.org/10.1080/21645515.2022.2031698 |
_version_ | 1784700010833641472 |
---|---|
author | Bianchi, Francesco Paolo Stefanizzi, Pasquale Lattanzio, Sabrina Diella, Giusy Germinario, Cinzia Annatea Tafuri, Silvio |
author_facet | Bianchi, Francesco Paolo Stefanizzi, Pasquale Lattanzio, Sabrina Diella, Giusy Germinario, Cinzia Annatea Tafuri, Silvio |
author_sort | Bianchi, Francesco Paolo |
collection | PubMed |
description | Pregnant women and newborns are considered a subgroup of population at increased risk for several infectious diseases, some of which are vaccine-preventable. Anti-diphtheria-tetanus-pertussis vaccine (dTpa) and influenza vaccine are recommended for pregnant women. We carried out a study to evaluate the knowledge of new mothers toward the main vaccine-preventable diseases and to assess their compliance with recommended vaccinations. Using the Hospital Discharge Forms (SDO), the list of women who gave birth in 2018 was generated. Women were interviewed by a questionnaire administered by telephone. The study sample consisted of 145 subjects, with an average age of 35.0 ± 5.9 years (range = 18.0–47.0). 5/145 (3.4%; 95% CI = 1.1–7.9%) subjects were advised during pregnancy to have the flu shot; only 1/145 (0.7%; 95% CI = 0.5–71.6%) reported the flu vaccine during the last pregnancy. 94/145 (64.8%; 95% CI = 57.2–73.2%) respondents declared that they had carried out the TORCH panel exams before pregnancy; of these 18/94 (19.2%; 95% C = 11.8–28.6%) were susceptible for rubella. Of these subjects, for 7/18 (38.9%; 95% CI = 17.3–64.3%) rubella vaccination was offered and 5/7 (71.4%; 95% CI = 29.0–96.3%) decided to carry out the vaccination. Only 1/145 (0.7%; 95% CI = 0.0–3.8%) of the interviewed woman underwent anti-dTap vaccination. Greater efforts must be made by public health institutions to raise awareness and improve vaccination compliance in this population. |
format | Online Article Text |
id | pubmed-9067467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-90674672022-05-05 Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study Bianchi, Francesco Paolo Stefanizzi, Pasquale Lattanzio, Sabrina Diella, Giusy Germinario, Cinzia Annatea Tafuri, Silvio Hum Vaccin Immunother Research Paper Pregnant women and newborns are considered a subgroup of population at increased risk for several infectious diseases, some of which are vaccine-preventable. Anti-diphtheria-tetanus-pertussis vaccine (dTpa) and influenza vaccine are recommended for pregnant women. We carried out a study to evaluate the knowledge of new mothers toward the main vaccine-preventable diseases and to assess their compliance with recommended vaccinations. Using the Hospital Discharge Forms (SDO), the list of women who gave birth in 2018 was generated. Women were interviewed by a questionnaire administered by telephone. The study sample consisted of 145 subjects, with an average age of 35.0 ± 5.9 years (range = 18.0–47.0). 5/145 (3.4%; 95% CI = 1.1–7.9%) subjects were advised during pregnancy to have the flu shot; only 1/145 (0.7%; 95% CI = 0.5–71.6%) reported the flu vaccine during the last pregnancy. 94/145 (64.8%; 95% CI = 57.2–73.2%) respondents declared that they had carried out the TORCH panel exams before pregnancy; of these 18/94 (19.2%; 95% C = 11.8–28.6%) were susceptible for rubella. Of these subjects, for 7/18 (38.9%; 95% CI = 17.3–64.3%) rubella vaccination was offered and 5/7 (71.4%; 95% CI = 29.0–96.3%) decided to carry out the vaccination. Only 1/145 (0.7%; 95% CI = 0.0–3.8%) of the interviewed woman underwent anti-dTap vaccination. Greater efforts must be made by public health institutions to raise awareness and improve vaccination compliance in this population. Taylor & Francis 2022-02-18 /pmc/articles/PMC9067467/ /pubmed/35180368 http://dx.doi.org/10.1080/21645515.2022.2031698 Text en © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way. |
spellingShingle | Research Paper Bianchi, Francesco Paolo Stefanizzi, Pasquale Lattanzio, Sabrina Diella, Giusy Germinario, Cinzia Annatea Tafuri, Silvio Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study |
title | Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study |
title_full | Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study |
title_fullStr | Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study |
title_full_unstemmed | Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study |
title_short | Attitude for vaccination prophylaxis among pregnant women: a cross-sectional study |
title_sort | attitude for vaccination prophylaxis among pregnant women: a cross-sectional study |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067467/ https://www.ncbi.nlm.nih.gov/pubmed/35180368 http://dx.doi.org/10.1080/21645515.2022.2031698 |
work_keys_str_mv | AT bianchifrancescopaolo attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy AT stefanizzipasquale attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy AT lattanziosabrina attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy AT diellagiusy attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy AT germinariocinziaannatea attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy AT tafurisilvio attitudeforvaccinationprophylaxisamongpregnantwomenacrosssectionalstudy |